9 insiders reported 45 Form 4 transactions for Athira Pharma, Inc. (ATHA) over the past 18 months (most recent 2026-01-05). Recent activity: Renninger Robert (Chief Financial Officer) Buy 1,000 shares, Renninger Robert (Chief Financial Officer) Buy 1,236 shares, Renninger Robert (Chief Financial Officer) Sell 297 shares, Worthington Mark (General Counsel and CCO) Buy 3,667 shares, Worthington Mark (General Counsel and CCO) Sell 876 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-05 | Renninger Robert | Chief Financial Officer | Buy | 1,000 | $2,310 |
| 2026-01-05 | Renninger Robert | Chief Financial Officer | Buy | 1,236 | $0 |
| 2026-01-05 | Renninger Robert | Chief Financial Officer | Sell | 297 | $2,043 |
| 2026-01-05 | Worthington Mark | General Counsel and CCO | Buy | 3,667 | $0 |
| 2026-01-05 | Worthington Mark | General Counsel and CCO | Sell | 876 | $6,027 |
| 2026-01-05 | Litton Mark James | President and CEO | Buy | 10,834 | $0 |
| 2026-01-05 | Litton Mark James | President and CEO | Sell | 2,586 | $17,792 |
| 2026-01-05 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | Buy | 1,000 | $2,310 |
| 2026-01-05 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | Buy | 3,667 | $0 |
| 2026-01-05 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | Sell | 876 | $6,027 |
| 2026-01-05 | San Martin Javier | CHIEF MEDICAL OFFICER | Buy | 4,667 | $0 |
| 2026-01-05 | San Martin Javier | CHIEF MEDICAL OFFICER | Sell | 1,644 | $11,311 |
| 2025-12-23 | EDELMAN JOSEPH | Director | Buy | 989,270 | $6.3M |
| 2025-12-23 | PERCEPTIVE ADVISORS LLC | Director | Buy | 989,270 | $6.3M |
| 2025-12-23 | PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | Director | Buy | 989,270 | $6.3M |
| 2025-12-23 | Perceptive Xontogeny Venture Fund II, LP | Director | Buy | 989,270 | $6.3M |
| 2025-12-23 | EDELMAN JOSEPH | Director | Buy | 329,756 | $2.1M |
| 2025-12-23 | PERCEPTIVE ADVISORS LLC | Director | Buy | 329,756 | $2.1M |
| 2025-12-23 | PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | Director | Buy | 329,756 | $2.1M |
| 2025-12-23 | Perceptive Xontogeny Venture Fund II, LP | Director | Buy | 329,756 | $2.1M |
| 2025-07-02 | Renninger Robert | SVP, Finance and Accounting | Buy | 10,000 | $2,300 |
| 2025-07-02 | Renninger Robert | SVP, Finance and Accounting | Buy | 12,359 | $0 |
| 2025-07-02 | Renninger Robert | SVP, Finance and Accounting | Sell | 2,897 | $840 |
| 2025-07-02 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | Buy | 10,000 | $2,300 |
| 2025-07-02 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | Buy | 36,666 | $0 |
Source: SEC Form 4 filings · as of 2026-01-05
